These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 11936264)

  • 1. Dysplasia in inflammatory bowel disease.
    Greenson JK
    Semin Diagn Pathol; 2002 Feb; 19(1):31-7. PubMed ID: 11936264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathobiology of dysplasia in chronic inflammatory bowel disease: Current recommendations for surveillance of dysplasia].
    Raithel M; Weidenhiller M; Schwab D; Müller S; Hahn EG
    Z Gastroenterol; 2001 Oct; 39(10):861-75. PubMed ID: 11605156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
    Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The malignant side of chronic inflammatory bowel disease].
    West RL; van de Vrie W; Schouten WR; van Dekken H; Kuipers EJ
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2521-4. PubMed ID: 12532661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysplasia in inflammatory bowel diseases.
    Mescoli C; Albertoni L; D'incá R; Rugge M
    Dig Liver Dis; 2013 Mar; 45(3):186-94. PubMed ID: 22974564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: colorectal carcinoma and inflammatory bowel disease.
    Eaden J
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():24-30. PubMed ID: 15352890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic problems and advances in inflammatory bowel disease.
    Odze R
    Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinogenesis in inflammatory bowel disease.
    Herszenyi L; Miheller P; Tulassay Z
    Dig Dis; 2007; 25(3):267-9. PubMed ID: 17827953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance for dysplasia in patients with inflammatory bowel disease: a national survey of colonoscopic practice in New Zealand.
    Gearry RB; Wakeman CJ; Barclay ML; Chapman BA; Collett JA; Burt MJ; Frizelle FA
    Dis Colon Rectum; 2004 Mar; 47(3):314-22. PubMed ID: 14991493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of CK7 and CK20 in preneoplastic and neoplastic lesions in ulcerative colitis.
    Stenling R; Lindberg J; Rutegård J; Palmqvist R
    APMIS; 2007 Nov; 115(11):1219-26. PubMed ID: 18092953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling dysplasia detection in ulcerative colitis: clinical implications of surveillance intensity.
    Awais D; Siegel CA; Higgins PD
    Gut; 2009 Nov; 58(11):1498-503. PubMed ID: 19651634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.
    Sjöqvist U; Tribukait B; Ost A; Einarsson C; Oxelmark L; Löfberg R
    Anticancer Res; 2004; 24(5B):3121-7. PubMed ID: 15510599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dysplasia in ulcerative colitis].
    Werner M; Mueller E
    Verh Dtsch Ges Pathol; 1999; 83():122-9. PubMed ID: 10714202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surveillance of patients with inflammatory bowel diseases].
    Moshkowitz M; Kariv R; Half B; Vilkin A; Levi Z; Niv Y; Dotan I;
    Harefuah; 2011 Apr; 150(4):389-91, 417. PubMed ID: 22164923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-gated fluorescence spectroscopy improves endoscopic detection of low-grade dysplasia in ulcerative colitis.
    Ortner MA; Fusco V; Ebert B; Sukowski U; Weber-Eibel J; Fleige B; Stolte M; Oberhuber G; Rinneberg H; Lochs H
    Gastrointest Endosc; 2010 Feb; 71(2):312-8. PubMed ID: 20003972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
    Dorer R; Odze RD
    Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis.
    Thomas T; Abrams KA; Robinson RJ; Mayberry JF
    Aliment Pharmacol Ther; 2007 Mar; 25(6):657-68. PubMed ID: 17311598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.
    Lindström L; Lapidus A; Ost A; Bergquist A
    Dis Colon Rectum; 2011 Nov; 54(11):1392-7. PubMed ID: 21979184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Premalignant and malignant changes in idiopathic inflammatory bowel disease].
    Knezević-Usaj S; Panisić M; Tarabar D; Cuk V; Brajuković G; Petrović M
    Acta Chir Iugosl; 2000; 47(1-2):43-50. PubMed ID: 10953365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.